GPT and metabolic dysfunction-associated steatotic liver disease: Therefore, SSd reduces gene-associated hepatic steatosis, significantly decreasing AST and ALT levels, and could improve NAFLD symptoms, mediating the mRNA expression of molecular mechanisms to affect hepatic lipid accumulation.